Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Net Margin (2021 - 2025)

Historic Net Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 29.24%.

  • MDxHealth's Net Margin rose 158400.0% to 29.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 30.15%, marking a year-over-year increase of 185700.0%. This contributed to the annual value of 42.28% for FY2024, which is 191300.0% up from last year.
  • MDxHealth's Net Margin amounted to 29.24% in Q3 2025, which was up 158400.0% from 27.71% recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Margin registered a high of 296959.74% during Q2 2022, and its lowest value of 138.69% during Q3 2021.
  • For the 5-year period, MDxHealth's Net Margin averaged around 17400.77%, with its median value being 52.02% (2024).
  • Examining YoY changes over the last 5 years, MDxHealth's Net Margin showed a top increase of 804100bps in 2023 and a maximum decrease of 2000000000bps in 2023.
  • Quarter analysis of 5 years shows MDxHealth's Net Margin stood at 134.41% in 2021, then rose by 30bps to 94.5% in 2022, then soared by 42bps to 55.25% in 2023, then surged by 51bps to 27.26% in 2024, then decreased by -7bps to 29.24% in 2025.
  • Its Net Margin stands at 29.24% for Q3 2025, versus 27.71% for Q2 2025 and 36.78% for Q1 2025.